Pharmarise Holdings

Basic Information

Stock Code
2796
Industry
Retail
Category Detail
Specialty Stores & Drugstores
Prefecture
Tokyo
Establishment Year
June 1984
Listing Year
February 2007
Official Website
https://www.pharmarise.com/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Bras, Quoll Holdings, Cosmos Chozai, Daiko, Nihon Chozai, Medical Ikko Group, F&F, Medical System Network, Mia Herusa Holdings, HYUGA PRIMARY CARE, Ain Holdings, Sapporo Clinical Laboratory Center, Hokue

Overview

Pharmarise Holdings is a core company operating insurance-dispensing pharmacies under a holding company structure established in 1984, providing community-based medical services through wide-area deployment.

Current Situation

Pharmarise Holdings achieved consolidated sales of approximately 54.5 billion yen in the fiscal year ending May 2024, focusing on the medical dispensing pharmacy business. Its main business is operating an insurance-dispensing pharmacy network from Hokkaido to the Kansai region, expanding market share through multi-store development by multiple subsidiaries. In recent years, it has actively utilized M&A to promote expansion of scale and improvement in management efficiency. Technologically, it is advancing sales of prescription data and strengthening management systems. For sustainability, it is committed to contributing to regional healthcare and improving employee work-life balance, while promoting development of new services in response to changes in the medical environment. Moving forward, it aims to further strengthen its business foundation through capital and business alliances, with a focus on enhancing the quality and expansion of regional healthcare. In 2024, it implemented focused business expansions such as acquiring operations from the Kanichi Shoten Group, establishing management stability and a growth strategy.

Trivia

Interesting Facts

  • Opened its first insurance-dispensing pharmacy in Bunkyo-ku, Tokyo in 1987.
  • Introduced holding company system and has been aggressively expanding via M&A since 2019.
  • Diverse subsidiary group including Sapporo Clinical Laboratory Center.
  • Also operates as a FamilyMart franchisee.
  • Features industry giant Suzuken as a capital and business alliance partner.
  • Operates an employee stock ownership plan to promote employee participation.
  • Headquartered in central Nakano-ku, Tokyo.
  • Dispensing pharmacy operations span from Hokkaido to Kansai.
  • Recognized as a mid-tier pharmacy firm handling prescription data sales.
  • Achieved listing upgrade to the First Section of the Tokyo Stock Exchange in 2015.

Hidden Connections

  • Promotes shared industry sales networks through capital and business alliance with Suzuken.
  • Developed new business formats through FamilyMart franchise expansion.
  • Revitalized multiple group companies as sponsor for Kanichi Shoten's corporate turnaround.
  • Core business involves building nationwide regional medical collaboration networks.
  • Holds numerous subsidiaries implementing diversified medical-related strategies.
  • Achieved long-term business growth since establishment as Tokyo Bussan in 1984.
  • Maintains strong ties with medical institutions through prescription data sales.
  • Balances community-based store operations with alliances with major players.

Future Outlook

Growth Drivers

  • Increasing home medical care demand due to aging society
  • Expansion of insurance-dispensing market linked to policies
  • Nationwide store network expansion via M&A
  • Advanced utilization of prescription data through IT
  • Strengthening of regional medical collaboration networks
  • New business format development through FamilyMart business alliance
  • Diversification and value enhancement of pharmaceutical services
  • Workstyle reforms to address pharmacist shortages
  • Business expansion and funding through capital and business alliances
  • Growing importance of medical services amid strengthened infection control measures

Strategic Goals

  • Establish dispensing pharmacy network in major regions nationwide
  • Achieve 20% sales ratio from home medical care services
  • Improve operational efficiency by 40% through advanced IT infrastructure
  • Gain recognition as a company fulfilling environmental and social responsibilities
  • Expand new business sales ratio to 30%
  • Create synergies through strengthened collaboration with capital alliance partners
  • Enhance customer satisfaction through greater contributions to regional healthcare
  • Maintain and improve employee satisfaction above 80%
  • Establish sustainable management base and stable profitability
  • Build diversified revenue portfolio through multi-business operations

Business Segments

Services for Medical Institutions

Overview
Provides prescription data and dispensing support services to medical institutions.
Competitiveness
Efficient data collaboration leveraging wide-area network
Customers
  • Hospitals
  • Clinics
  • Medical offices
  • Nursing facilities
  • Home nursing stations
  • Regional medical collaboration organizations
Products
  • Prescription data sales
  • Drug information management system
  • Dispensing support services
  • Medical consulting
  • Home medical care support services

Pharmacy Franchise Support

Overview
Provides various services to support the establishment and operation of pharmacies.
Competitiveness
High support capabilities based on diverse store operation experience
Customers
  • Local pharmacy owners
  • Medical-related entrepreneurs
  • Investors
Products
  • Store operation know-how provision
  • Brand operation support
  • Management consulting
  • Human resource development programs

Logistics and Dispensing Equipment Sales

Overview
Sells efficient logistics and equipment to dispensing pharmacies.
Competitiveness
System provision leveraging proprietary know-how
Customers
  • Dispensing pharmacies
  • Pharmaceutical wholesalers
Products
  • Dispensing equipment
  • Pharmaceutical logistics systems
  • Inventory management software

Pharmaceutical Information Provision

Overview
Provides the latest pharmaceutical market information and analysis data.
Competitiveness
Industry-expert analytical capabilities
Customers
  • Pharmaceutical companies
  • Medical professionals
Products
  • Market data reports
  • Pharmaceutical trend analysis
  • Sales forecasting services

Competitive Advantage

Strengths

  • Wide-area dispensing pharmacy network
  • Group strategy under holding company
  • Expansion through aggressive M&A
  • Utilization of abundant prescription data
  • Community-based service deployment
  • High pharmacist expertise and customer service
  • Diversification through numerous subsidiaries
  • Growth support via capital and business alliances
  • Employee motivation through stock ownership plan
  • Focus on contributing to regional healthcare

Competitive Advantages

  • Stable supply via nationwide insurance-dispensing pharmacy network
  • Unique medical services utilizing prescription data
  • Efficient sharing of management resources among group subsidiaries
  • Convenience store expansion through FamilyMart partnership
  • Rapid store expansion and market share growth via M&A
  • Management support based on extensive know-how and experience
  • Organizational unity through employee stock ownership plan
  • Strengthened collaboration with industry leaders via capital and business alliances
  • Response to medical needs through enhanced home medical care support
  • Flexible management strategy implementation under new holding company structure

Threats

  • Profit pressure from medical system legal revisions
  • Intense store expansion competition from rivals
  • Fluctuations in regional healthcare demand due to population decline
  • Challenges in securing pharmacists amid shortages
  • Cost increases from consumption tax and other legal changes
  • Deteriorating profitability due to rising pharmacy operating costs
  • Delays in responding to medical IT advancements
  • Increased new market entrants and price competition

Innovations

2024: Acquisition of 54 Stores from Kanichi Shoten Group

Overview
Acquired 54 pharmacy operations amid group reorganization to expand management base.
Impact
Successfully expanded store network and strengthened regional medical collaboration.

2023: Capital and Business Alliance Agreement with Suzuken Co., Ltd.

Overview
Strengthened management base through capital and business alliance with industry leader.
Impact
Contributes to enhanced competitiveness via financial strength and business collaboration.

2020: Full Subsidiary Acquisition of Healthy Work Co., Ltd.

Overview
Acquired subsidiary to expand health management and dispensing services.
Impact
Contributed to service diversification and regional market share expansion.

2023: Transfer of Dispensing Operations to Hokkaido Pharmarise

Overview
Transferred Hokkaido dispensing pharmacy operations to specialized subsidiary to enhance expertise.
Impact
Achieved efficient operations through regional specialization strategy.

2024: Organizational Efficiency via Absorption Merger of Wholly-owned Subsidiaries

Overview
Merged multiple group subsidiaries to improve management efficiency.
Impact
Achieved cost reductions and organizational revitalization.

Sustainability

  • Health support activities promoting regional medical collaboration
  • Workstyle reforms and enhanced employee welfare
  • Comprehensive infection prevention measures
  • Disaster support for local communities and participation in disaster prevention activities
  • Development and promotion of home medical services for the elderly